Search | Virtual Health Library

1.

Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.

Gaiti, Federico; Chaligne, Ronan; Gu, Hongcang; Brand, Ryan M; Kothen-Hill, Steven; Schulman, Rafael C; Grigorev, Kirill; Risso, Davide; Kim, Kyu-Tae; Pastore, Alessandro; Huang, Kevin Y; Alonso, Alicia; Sheridan, Caroline; Omans, Nathaniel D; Biederstedt, Evan; Clement, Kendell; Wang, Lili; Felsenfeld, Joshua A; Bhavsar, Erica B; Aryee, Martin J; Allan, John N; Furman, Richard; Gnirke, Andreas; Wu, Catherine J; Meissner, Alexander; Landau, Dan A.

Nature ; 569(7757): 576-580, 2019 05.

Article in English | MEDLINE | ID: mdl-31092926

2.

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.

Tam, Constantine S; Allan, John N; Siddiqi, Tanya; Kipps, Thomas J; Jacobs, Ryan; Opat, Stephen; Barr, Paul M; Tedeschi, Alessandra; Trentin, Livio; Bannerji, Rajat; Jackson, Sharon; Kuss, Bryone J; Moreno, Carol; Szafer-Glusman, Edith; Russell, Kristin; Zhou, Cathy; Ninomoto, Joi; Dean, James P; Wierda, William G; Ghia, Paolo.

Blood ; 139(22): 3278-3289, 2022 06 02.

Article in English | MEDLINE | ID: mdl-35196370

3.

Synergistic efficacy of the dual PI3K-Î´/Î³ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models.

Iannello, Andrea; Vitale, Nicoletta; Coma, Silvia; Arruga, Francesca; Chadburn, Amy; Di Napoli, Arianna; Laudanna, Carlo; Allan, John N; Furman, Richard R; Pachter, Jonathan A; Deaglio, Silvia; Vaisitti, Tiziana.

Blood ; 137(24): 3378-3389, 2021 06 17.

Article in English | MEDLINE | ID: mdl-33786583

4.

ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.

Vaisitti, Tiziana; Arruga, Francesca; Vitale, Nicoletta; Lee, Thanh-Trang; Ko, Mira; Chadburn, Amy; Braggio, Esteban; Di Napoli, Arianna; Iannello, Andrea; Allan, John N; Miller, Langdon L; Lannutti, Brian J; Furman, Richard R; Jessen, Katti A; Deaglio, Silvia.

Blood ; 137(24): 3365-3377, 2021 06 17.

Article in English | MEDLINE | ID: mdl-33512452

5.

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

Arruga, Francesca; Rubin, Marta; Papazoglou, Despoina; Iannello, Andrea; Ioannou, Nikolaos; Moia, Riccardo; Rossi, Davide; Gaidano, Gianluca; Coscia, Marta; Laurenti, Luca; D'Arena, Giovanni; Allan, John N; Furman, Richard R; Vaisitti, Tiziana; Ramsay, Alan G; Deaglio, Silvia.

Haematologica ; 108(8): 2101-2115, 2023 08 01.

Article in English | MEDLINE | ID: mdl-36655432

6.

Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia.

Mejia Saldarriaga, Mateo; Alhomoud, Mohammad; Roboz, Gail; Allan, John N; Ruan, Jia; Ouseph, Madhu M; Simonson, Paul D; Bustoros, Mark; Niesvizky, Ruben.

Am J Hematol ; 98(7): 1119-1126, 2023 07.

Article in English | MEDLINE | ID: mdl-36785525

7.

Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

SahBandar, Ivo N; Sy, Chandler B; van den Akker, Tayler; Kim, David; Geyer, Julia T; Chadburn, Amy; Cesarman, Ethel; Inghirami, Giorgio; Allan, John N; Siddiqui, Momin T; Ouseph, Madhu M.

Pathobiology ; 90(5): 356-364, 2023.

Article in English | MEDLINE | ID: mdl-36996787

8.

Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.

Allan, John N; Shanafelt, Tait; Wiestner, Adrian; Moreno, Carol; O'Brien, Susan M; Li, Jianling; Krigsfeld, Gabriel; Dean, James P; Ahn, Inhye E.

Br J Haematol ; 196(4): 947-953, 2022 02.

Article in English | MEDLINE | ID: mdl-34865212

9.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience.

Mato, Anthony R; Roeker, Lindsey E; Lamanna, Nicole; Allan, John N; Leslie, Lori; Pagel, John M; Patel, Krish; Osterborg, Anders; Wojenski, Daniel; Kamdar, Manali; Huntington, Scott F; Davids, Matthew S; Brown, Jennifer R; Antic, Darko; Jacobs, Ryan; Ahn, Inhye E; Pu, Jeffrey; Isaac, Krista M; Barr, Paul M; Ujjani, Chaitra S; Geyer, Mark B; Berman, Ellin; Zelenetz, Andrew D; Malakhov, Nikita; Furman, Richard R; Koropsak, Michael; Bailey, Neil; Hanson, Lotta; Perini, Guilherme F; Ma, Shuo; Ryan, Christine E; Wiestner, Adrian; Portell, Craig A; Shadman, Mazyar; Chong, Elise A; Brander, Danielle M; Sundaram, Suchitra; Seddon, Amanda N; Seymour, Erlene; Patel, Meera; Martinez-Calle, Nicolas; Munir, Talha; Walewska, Renata; Broom, Angus; Walter, Harriet; El-Sharkawi, Dima; Parry, Helen; Wilson, Matthew R; Patten, Piers E M; Hernández-Rivas, José-Ángel.

Blood ; 136(10): 1134-1143, 2020 09 03.

Article in English | MEDLINE | ID: mdl-32688395

10.

Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia.

Rogers, Kerry A; Thompson, Philip A; Allan, John N; Coleman, Morton; Sharman, Jeff P; Cheson, Bruce D; Jones, Daniel; Izumi, Raquel; Frigault, Melanie M; Quah, Cheng; Raman, Rakesh K; Patel, Priti; Wang, Min Hui; Kipps, Thomas J.

Haematologica ; 106(9): 2364-2373, 2021 09 01.

Article in English | MEDLINE | ID: mdl-33730844

11.

Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.

Forsberg, Peter A; Rossi, Adriana C; Boyer, Angelique; Pearse, Roger N; Pekle, Karen A; Jayabalan, David; Lakritz, Stephanie; Flicker, Kari; Ribadeneyra, Drew; Liotta, Brielle; Ely, Scott; Boussi, Leora; Allan, John N; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M.

Am J Hematol ; 96(12): 1554-1562, 2021 12 01.

Article in English | MEDLINE | ID: mdl-34424561

12.

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

Eyre, Toby A; Roeker, Lindsey E; Fox, Christopher P; Gohill, Satyen H; Walewska, Renata; Walter, Harriet S; Forconi, Francesco; Broom, Angus; Arumainathan, Arvind; Brander, Danielle M; Allan, John N; Schuster, Stephen J; Hill, Brian T; Lansigan, Frederick; Cheson, Bruce D; Lamanna, Nicole; Coombs, Catherine C; Barr, Paul M; Skarbnik, Alan P; Shadman, Mazyar; Ujjani, Chaitra S; Pearson, Laurie; Pagel, John M; Jacobs, Ryan; Mato, Anthony R.

Br J Haematol ; 188(6): 918-923, 2020 03.

Article in English | MEDLINE | ID: mdl-31682002

13.

Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis.

Liu, Yen-Chun; Margolskee, Elizabeth; Allan, John N; Mathew, Susan; Bhavsar, Erica; Casano, Joseph; Orazi, Attilio; Furman, Richard R; Geyer, Julia T.

Mod Pathol ; 33(3): 344-353, 2020 03.

Article in English | MEDLINE | ID: mdl-31477813

14.

Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.

Forsberg, Peter A; Rossi, Adriana C; Boyer, Angelique; Tegnestam, Linda; Pearse, Roger N; Perry, Arthur; Pekle, Karen A; Jayabalan, David; Ely, Scott; Boussi, Leora; Sherbenou, Daniel W; Williams, Colt; Allan, John N; Coleman, Morton; Niesvizky, Ruben; Mark, Tomer M.

Am J Hematol ; 94(5): 539-545, 2019 05.

Article in English | MEDLINE | ID: mdl-30740766

15.

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.

Roeker, Lindsey E; Eyre, Toby A; Thompson, Meghan C; Lamanna, Nicole; Coltoff, Alexander R; Davids, Matthew S; Baker, Peter O; Leslie, Lori; Rogers, Kerry A; Allan, John N; Cordoba, Raul; Lopez-Garcia, Alberto; Antic, Darko; Pagel, John M; Martinez-Calle, Nicolas; García-Marco, José Antonio; Hernández-Rivas, Jose-Ángel; Miras, Fatima; Coombs, Catherine C; Österborg, Anders; Hansson, Lotta; Seddon, Amanda N; López Jiménez, Javier; Wilson, Matthew R; El-Sharkawi, Dima; Wojenski, Daniel; Ma, Shuo; Munir, Talha; Valenciano, Susana; Seymour, Erlene; Barr, Paul M; Pu, Jeffrey; Patten, Piers E M; Perini, Guilherme F; Huntington, Scott F; Parry, Helen; Sundaram, Suchitra; Skarbnik, Alan; Kamdar, Manali; Jacobs, Ryan; Walter, Harriet; Walewska, Renata; Broom, Angus; Lebowitz, Sonia; Isaac, Krista M; Portell, Craig A; Ahn, Inhye E; Ujjani, Chaitra S; Shadman, Mazyar; Skånland, Sigrid S.

Blood ; 138(18): 1768-1773, 2021 11 04.

Article in English | MEDLINE | ID: mdl-34297826

16.

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

Mato, Anthony R; Thompson, Meghan; Allan, John N; Brander, Danielle M; Pagel, John M; Ujjani, Chaitra S; Hill, Brian T; Lamanna, Nicole; Lansigan, Frederick; Jacobs, Ryan; Shadman, Mazyar; Skarbnik, Alan P; Pu, Jeffrey J; Barr, Paul M; Sehgal, Alison R; Cheson, Bruce D; Zent, Clive S; Tuncer, Hande H; Schuster, Stephen J; Pickens, Peter V; Shah, Nirav N; Goy, Andre; Winter, Allison M; Garcia, Christine; Kennard, Kaitlin; Isaac, Krista; Dorsey, Colleen; Gashonia, Lisa M; Singavi, Arun K; Roeker, Lindsey E; Zelenetz, Andrew; Williams, Annalynn; Howlett, Christina; Weissbrot, Hanna; Ali, Naveed; Khajavian, Sirin; Sitlinger, Andrea; Tranchito, Eve; Rhodes, Joanna; Felsenfeld, Joshua; Bailey, Neil; Patel, Bhavisha; Burns, Timothy F; Yacur, Melissa; Malhotra, Mansi; Svoboda, Jakub; Furman, Richard R; Nabhan, Chadi.

Haematologica ; 103(9): 1511-1517, 2018 09.

Article in English | MEDLINE | ID: mdl-29880613

17.

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.

Mato, Anthony R; Roeker, Lindsey E; Allan, John N; Pagel, John M; Brander, Danielle M; Hill, Brian T; Cheson, Bruce D; Furman, Richard R; Lamanna, Nicole; Tam, Constantine S; Handunnetti, Sasanka; Jacobs, Ryan; Lansigan, Frederick; Bhavsar, Erica; Barr, Paul M; Shadman, Mazyar; Skarbnik, Alan P; Goy, Andre; Beach, Douglas F; Svoboda, Jakub; Pu, Jeffrey J; Sehgal, Alison R; Zent, Clive S; Tuncer, Hande H; Schuster, Stephen J; Pickens, Peter V; Shah, Nirav N; Rhodes, Joanna; Ujjani, Chaitra S; Nabhan, Chadi.

Am J Hematol ; 93(11): 1394-1401, 2018 11.

Article in English | MEDLINE | ID: mdl-30132965

18.

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.

Vaisitti, Tiziana; Gaudino, Federica; Ouk, Samedy; Moscvin, Maria; Vitale, Nicoletta; Serra, Sara; Arruga, Francesca; Zakrzewski, Johannes L; Liou, Hsiou-Chi; Allan, John N; Furman, Richard R; Deaglio, Silvia.

Haematologica ; 102(11): 1878-1889, 2017 11.

Article in English | MEDLINE | ID: mdl-28860341

19.

Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies.

Allan, John N; Pinilla-Ibarz, Javier; Gladstone, Douglas E; Patel, Krish; Sharman, Jeff P; Wierda, William G; Choi, Michael Y; O'Brien, Susan M; Shadman, Mazyar; Davids, Matthew S; Pagel, John M; Yimer, Habte A; Ward, Renee; Acton, Gary; Taverna, Pietro; Combs, Daniel L; Fox, Judith A; Furman, Richard R; Brown, Jennifer R.

Haematologica ; 107(4): 984-987, 2022 04 01.

Article in English | MEDLINE | ID: mdl-34937320

20.

The clinical importance of prognostic markers in CLL.

Allan, John N.

Clin Adv Hematol Oncol ; 20(10): 606-608, 2022 10.

Article in English | MEDLINE | ID: mdl-36206072

Virtual Health Library

United States - Mexico Border

Your selection (0)

Export format:

Export: